Home Biosimilar Antibodies Others Others antibody Alsevalimab (Anti-B7-H4 / VTCN1) For research use only.
Not for use in humans.

Alsevalimab (Anti-B7-H4 / VTCN1)

Synonyms: FPA 150

Alsevalimab (Anti-B7-H4 / VTCN1) is a human monoclonal antibody targeting B7-H4. It has potential antineoplastic and immune checkpoint inhibitory activities. MW :144.74 KD.

Alsevalimab (Anti-B7-H4 / VTCN1)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 9.93mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Alsevalimab (Anti-B7-H4 / VTCN1) is a human monoclonal antibody targeting B7-H4. It has potential antineoplastic and immune checkpoint inhibitory activities. MW :144.74 KD.

Product Details

CAS No. 2254029-91-7
Molecular Weight 144.74
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Alsevalimab (Anti-B7-H4 / VTCN1) | Alsevalimab (Anti-B7-H4 / VTCN1) supplier | purchase Alsevalimab (Anti-B7-H4 / VTCN1) | Alsevalimab (Anti-B7-H4 / VTCN1) cost | Alsevalimab (Anti-B7-H4 / VTCN1) manufacturer | order Alsevalimab (Anti-B7-H4 / VTCN1) | Alsevalimab (Anti-B7-H4 / VTCN1) distributor